
The pharmaceutical industry is known for its relative stability and resilience, even during economic downturns. This is due to the consistent demand for medications and healthcare, regardless of market conditions.
Therefore, it could be wise to secure your portfolio with three fundamentally robust pharma stocks, AstraZeneca PLC (AZN), Bristol-Myers Squibb Company (BMY), and Astellas Pharma Inc. (ALPMY), which seem well-positioned to weather macroeconomic challenges.